Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Immunoglobulin Fab Fragments"" wg kryterium: Temat


Wyświetlanie 1-19 z 19
Tytuł:
Intracoronary compared to intravenous bolus abciximab during primary percutaneous coronary intervention in ST-segment Elevation Myocardial Infarction (STEMI) patients reduces 30-day mortality and target vessel revascularization: a randomized trial.
Autorzy:
Iversen A; Department of Cardiology, Gentofte University Hospital, Copenhagen, Denmark. />Abildgaard U
Galloe A
Hansen PR
Galatius S
Madsen JK
Engstroem T
Pedersen S
Jensen KS
Jensen JS
Pokaż więcej
Źródło:
Journal of interventional cardiology [J Interv Cardiol] 2011 Apr; Vol. 24 (2), pp. 105-11. Date of Electronic Publication: 2010 Dec 22.
Typ publikacji:
Comparative Study; Journal Article; Randomized Controlled Trial
MeSH Terms:
Angioplasty, Balloon, Coronary*
Antibodies, Monoclonal/*therapeutic use
Coronary Vessels/*pathology
Immunoglobulin Fab Fragments/*therapeutic use
Myocardial Infarction/*therapy
Myocardial Revascularization/*methods
Abciximab ; Antibodies, Monoclonal/adverse effects ; Drug Administration Routes ; Female ; Humans ; Immunoglobulin Fab Fragments/adverse effects ; Injections, Intra-Arterial ; Injections, Intravenous ; Male ; Myocardial Infarction/mortality ; Treatment Outcome
Czasopismo naukowe
Tytuł:
A longitudinal analysis of outcomes associated with abciximab and eptifibatide in a consecutive series of 3074 percutaneous coronary interventions.
Autorzy:
Long KH; Department of Health Sciences Research, Division of Health Care Policy and Research, Mayo Clinic College of Medicine, Rochester, MN 55905, USA. />Ting HH
McMurtry EK
Lennon RJ
Wood DL
Holmes DR Jr
Raveendran G
Rihal CS
Pokaż więcej
Źródło:
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research [Value Health] 2008 May-Jun; Vol. 11 (3), pp. 462-9.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Angioplasty, Balloon, Coronary*/economics
Outcome Assessment, Health Care*
Antibodies, Monoclonal/*therapeutic use
Immunoglobulin Fab Fragments/*therapeutic use
Peptides/*therapeutic use
Platelet Aggregation Inhibitors/*therapeutic use
Abciximab ; Antibodies, Monoclonal/economics ; Coronary Angiography ; Cost-Benefit Analysis ; Eptifibatide ; Humans ; Immunoglobulin Fab Fragments/economics ; Length of Stay/statistics & numerical data ; Logistic Models ; Longitudinal Studies ; Peptides/economics ; Platelet Aggregation Inhibitors/economics ; Proportional Hazards Models ; Prospective Studies ; Registries ; Statistics, Nonparametric
Czasopismo naukowe
Tytuł:
Safety, inhibition of platelet aggregation and pharmacokinetics of Fab'2 fragments of the anti-glycoprotein IIb-IIIa monoclonal antibody FRaMon in high-risk coronary angioplasty.
Autorzy:
Mazurov AV; Cardiology Research Center, Moscow, Russia. />Pevzner DV
Antonova OA
Byzova TV
Khaspekova SG
Semenov AV
Vlasik TN
Samko AN
Staroverov II
Ruda MY
Pokaż więcej
Źródło:
Platelets [Platelets] 2002 Dec; Vol. 13 (8), pp. 465-77.
Typ publikacji:
Clinical Trial; Comparative Study; Controlled Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Angioplasty, Balloon, Coronary/*adverse effects
Antibodies, Monoclonal/*therapeutic use
Immunoglobulin Fab Fragments/*therapeutic use
Platelet Aggregation Inhibitors/*pharmacology
Platelet Aggregation Inhibitors/*therapeutic use
Platelet Glycoprotein GPIIb-IIIa Complex/*immunology
Abciximab ; Animals ; Antibodies/blood ; Antibodies, Monoclonal/adverse effects ; Enzyme-Linked Immunosorbent Assay ; Female ; Humans ; Immunoglobulin Fab Fragments/adverse effects ; Immunoglobulin Fab Fragments/metabolism ; Male ; Mice ; Middle Aged ; Platelet Aggregation/drug effects ; Platelet Aggregation Inhibitors/pharmacokinetics ; Platelet Count ; Reoperation ; Risk Assessment ; Safety
Czasopismo naukowe
Tytuł:
Outcomes at 1 year and economic implications of platelet glycoprotein IIb/IIIa blockade in patients undergoing coronary stenting: results from a multicentre randomised trial. EPISTENT Investigators. Evaluation of Platelet IIb/IIIa Inhibitor for Stenting.
Autorzy:
Topol EJ; Department of Cardiology, Cleveland Clinic Foundation, OH 44195, USA. />Mark DB
Lincoff AM
Cohen E
Burton J
Kleiman N
Talley D
Sapp S
Booth J
Cabot CF
Anderson KM
Califf RM
Pokaż więcej
Źródło:
Lancet (London, England) [Lancet] 1999 Dec 11; Vol. 354 (9195), pp. 2019-24.
Typ publikacji:
Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial
MeSH Terms:
Angioplasty, Balloon, Coronary*/economics
Stents*/economics
Antibodies, Monoclonal/*administration & dosage
Coronary Disease/*therapy
Immunoglobulin Fab Fragments/*administration & dosage
Platelet Aggregation Inhibitors/*administration & dosage
Platelet Glycoprotein GPIIb-IIIa Complex/*antagonists & inhibitors
Abciximab ; Adult ; Aged ; Antibodies, Monoclonal/adverse effects ; Antibodies, Monoclonal/economics ; Coronary Disease/blood ; Coronary Disease/economics ; Coronary Disease/mortality ; Cost-Benefit Analysis ; Death, Sudden, Cardiac/prevention & control ; Female ; Follow-Up Studies ; Humans ; Immunoglobulin Fab Fragments/adverse effects ; Immunoglobulin Fab Fragments/economics ; Male ; Middle Aged ; Platelet Aggregation Inhibitors/adverse effects ; Platelet Aggregation Inhibitors/economics ; Survival Rate ; Treatment Outcome
Czasopismo naukowe
Tytuł:
Efficacy and safety of abciximab in diabetic patients who underwent percutaneous coronary intervention with thienopyridines loading: a meta-analysis.
Autorzy:
Wu Y; Department of Cardiology, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
Shi Y
Wu H
Bian C
Tang Q
Xu G
Yang J
Pokaż więcej
Źródło:
PloS one [PLoS One] 2011; Vol. 6 (6), pp. e20759. Date of Electronic Publication: 2011 Jun 03.
Typ publikacji:
Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't
MeSH Terms:
Angioplasty, Balloon, Coronary*
Antibodies, Monoclonal/*therapeutic use
Diabetes Mellitus/*drug therapy
Diabetes Mellitus/*surgery
Immunoglobulin Fab Fragments/*therapeutic use
Platelet Aggregation Inhibitors/*therapeutic use
Thienopyridines/*therapeutic use
Abciximab ; Aged ; Coronary Artery Disease/etiology ; Coronary Artery Disease/therapy ; Databases, Factual ; Diabetes Complications ; Humans ; Male ; Middle Aged ; Randomized Controlled Trials as Topic ; Sensitivity and Specificity ; Treatment Outcome
Czasopismo naukowe
Tytuł:
Intracoronary versus intravenous abciximab in ST-segment elevation myocardial infarction: rationale and design of the CICERO trial in patients undergoing primary percutaneous coronary intervention with thrombus aspiration.
Autorzy:
Gu YL; Department of Cardiology, Thorax Center, University Medical Center Groningen, University of Groningen, Hanzeplein 1 PO Box 30001, 9700 RB Groningen, the Netherlands. />Fokkema ML
Kampinga MA
de Smet BJ
Tan ES
van den Heuvel AF
Zijlstra F
Pokaż więcej
Źródło:
Trials [Trials] 2009 Sep 28; Vol. 10, pp. 90. Date of Electronic Publication: 2009 Sep 28.
Typ publikacji:
Comparative Study; Journal Article; Randomized Controlled Trial
MeSH Terms:
Angioplasty, Balloon, Coronary*
Electrocardiography*
Research Design*
Antibodies, Monoclonal/*administration & dosage
Anticoagulants/*administration & dosage
Immunoglobulin Fab Fragments/*administration & dosage
Myocardial Infarction/*drug therapy
Abciximab ; Coronary Angiography ; Humans ; Prospective Studies ; Sample Size ; Thrombosis/drug therapy
Czasopismo naukowe
Tytuł:
Impact of thienopyridine administration prior to primary stenting in acute myocardial infarction.
Autorzy:
Rabbani LE; Columbia University Medical Center, Cardiovascular Research Foundation, New York, New York 10032, USA.
Iyengar S
Dangas GD
Grines CL
Cox DA
Garcia E
Tcheng JE
Griffin JJ
Guagliumi G
Stuckey T
Turco M
Stant J
Fahy M
Lansky AJ
Mehran R
Stone GW
Pokaż więcej
Źródło:
Journal of interventional cardiology [J Interv Cardiol] 2009 Aug; Vol. 22 (4), pp. 378-84. Date of Electronic Publication: 2009 May 28.
Typ publikacji:
Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial
MeSH Terms:
Angioplasty, Balloon, Coronary*
Drug-Eluting Stents*
Myocardial Infarction/*drug therapy
Pyridines/*therapeutic use
Abciximab ; Aged ; Antibodies, Monoclonal/therapeutic use ; Aspirin/therapeutic use ; Confidence Intervals ; Drug Therapy, Combination ; Female ; Humans ; Immunoglobulin Fab Fragments/therapeutic use ; Kaplan-Meier Estimate ; Male ; Middle Aged ; Multivariate Analysis ; Myocardial Infarction/therapy ; Myocardial Revascularization/methods ; Odds Ratio ; Platelet Aggregation Inhibitors/therapeutic use ; Preoperative Care ; Time Factors
Czasopismo naukowe
Tytuł:
Glycoprotein IIb/IIIa receptor inhibitors in 2008: do they still have a role?
Autorzy:
Mukherjee D; Gill Heart Institute, Division of Cardiovascular Medicine, University of Kentucky, Lexington, Kentucky 40536-0200, USA. />Roffi M
Pokaż więcej
Źródło:
Journal of interventional cardiology [J Interv Cardiol] 2008 Apr; Vol. 21 (2), pp. 118-21.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Angioplasty, Balloon, Coronary*
Antibodies, Monoclonal/*therapeutic use
Blood Platelets/*drug effects
Immunoglobulin Fab Fragments/*therapeutic use
Platelet Aggregation Inhibitors/*therapeutic use
Platelet Glycoprotein GPIIb-IIIa Complex/*antagonists & inhibitors
Abciximab ; Acute Coronary Syndrome/drug therapy ; Europe ; Humans ; Myocardial Infarction/drug therapy ; Practice Guidelines as Topic ; United States
Czasopismo naukowe
Czasopismo naukowe
Tytuł:
Cost and effectiveness of glycoprotein IIb/IIIa-receptor inhibitors in patients with acute myocardial infarction undergoing percutaneous coronary intervention.
Autorzy:
McCollam PL; Lilly Research Laboratories, Eli Lilly & Co., Indianapolis, IN, USA. mccollam_patrick_ />Foster DA
Riesmeyer JS
Pokaż więcej
Źródło:
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists [Am J Health Syst Pharm] 2003 Jun 15; Vol. 60 (12), pp. 1251-6.
Typ publikacji:
Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Angioplasty, Balloon, Coronary/*statistics & numerical data
Myocardial Infarction/*drug therapy
Myocardial Infarction/*surgery
Platelet Glycoprotein GPIIb-IIIa Complex/*antagonists & inhibitors
Abciximab ; Aged ; Antibodies, Monoclonal/economics ; Antibodies, Monoclonal/therapeutic use ; Case-Control Studies ; Drug Costs/statistics & numerical data ; Eptifibatide ; Female ; Hospital Costs/statistics & numerical data ; Hospital Mortality ; Humans ; Immunoglobulin Fab Fragments/economics ; Immunoglobulin Fab Fragments/therapeutic use ; Length of Stay/statistics & numerical data ; Male ; Middle Aged ; Myocardial Infarction/mortality ; Outcome and Process Assessment, Health Care ; Peptides/economics ; Peptides/therapeutic use ; Platelet Aggregation Inhibitors/economics ; Platelet Aggregation Inhibitors/therapeutic use ; Platelet Glycoprotein GPIIb-IIIa Complex/economics ; Tirofiban ; Treatment Outcome ; Tyrosine/analogs & derivatives ; Tyrosine/economics ; Tyrosine/therapeutic use ; United States/epidemiology
Czasopismo naukowe
Tytuł:
Predictors of bleeding complications and thrombocytopenia with the use of abciximab during percutaneous coronary intervention.
Autorzy:
Razakjr OA; National University Hospital, Singapore. />Tan HC
Yip WL
Lim YT
Pokaż więcej
Źródło:
Journal of interventional cardiology [J Interv Cardiol] 2005 Feb; Vol. 18 (1), pp. 33-7.
Typ publikacji:
Journal Article
MeSH Terms:
Angioplasty, Balloon, Coronary*/adverse effects
Antibodies, Monoclonal/*adverse effects
Hemorrhage/*chemically induced
Immunoglobulin Fab Fragments/*adverse effects
Platelet Aggregation Inhibitors/*adverse effects
Thrombocytopenia/*chemically induced
Abciximab ; Adult ; Aged ; Humans ; Male ; Middle Aged ; Prospective Studies ; Risk Factors
Czasopismo naukowe
Tytuł:
Relationship between size of myocardial infarctions assessed by delayed contrast-enhanced MRI after primary PCI, biochemical markers, and time to intervention.
Autorzy:
Haase J; Red Cross Hospital Cardiology Center, Frankfurt/Main, Germany. />Bayar R
Hackenbroch M
Störger H
Hofmann M
Schwarz CE
Reinemer H
Schwarz F
Ruef J
Sommer T
Pokaż więcej
Źródło:
Journal of interventional cardiology [J Interv Cardiol] 2004 Dec; Vol. 17 (6), pp. 367-73.
Typ publikacji:
Journal Article
MeSH Terms:
Angioplasty, Balloon, Coronary*
Abciximab ; Aged ; Antibodies, Monoclonal/therapeutic use ; C-Reactive Protein/analysis ; Creatine Kinase/blood ; Female ; Humans ; Immunoglobulin Fab Fragments/therapeutic use ; Magnetic Resonance Imaging ; Male ; Middle Aged ; Myocardium/pathology ; Necrosis ; Platelet Glycoprotein GPIIb-IIIa Complex/therapeutic use ; Prospective Studies
Czasopismo naukowe
Tytuł:
Incidence and predictors of major vascular complications after percutaneous coronary intervention in the glycoprotein IIb/IIIa platelet inhibitor era.
Autorzy:
Konstance R; Duke University Medical Center, Durham, North Carolina, USA.
Tcheng JE
Wightman MB
Kelly LP
Moore A
Harrison JK
Sketch MH Jr
Pokaż więcej
Źródło:
Journal of interventional cardiology [J Interv Cardiol] 2004 Apr; Vol. 17 (2), pp. 65-70.
Typ publikacji:
Journal Article
MeSH Terms:
Angioplasty, Balloon, Coronary/*adverse effects
Antibodies, Monoclonal/*adverse effects
Immunoglobulin Fab Fragments/*adverse effects
Peptides/*adverse effects
Platelet Aggregation Inhibitors/*adverse effects
Vascular Diseases/*etiology
Abciximab ; Aged ; Eptifibatide ; Female ; Humans ; Incidence ; Male ; Middle Aged ; Platelet Glycoprotein GPIIb-IIIa Complex/antagonists & inhibitors ; Predictive Value of Tests ; Retrospective Studies ; Risk Factors ; Stents/adverse effects ; Vascular Diseases/epidemiology
Czasopismo naukowe
Tytuł:
Efficacy of glycoprotein IIb/IIIa-receptor inhibitors during percutaneous coronary intervention.
Autorzy:
Cheng JW; Long Island University, Mount Sinai Medical Center, Box 1211, One Gustave L. Levy Place, New York, NY 10029-6574, USA.
Pokaż więcej
Źródło:
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists [Am J Health Syst Pharm] 2002 Nov 01; Vol. 59 (21 Suppl 7), pp. S5-14.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't; Review
MeSH Terms:
Angioplasty, Balloon, Coronary*
Antibodies, Monoclonal/*therapeutic use
Coronary Disease/*drug therapy
Immunoglobulin Fab Fragments/*therapeutic use
Peptides/*therapeutic use
Platelet Aggregation Inhibitors/*therapeutic use
Platelet Glycoprotein GPIIb-IIIa Complex/*antagonists & inhibitors
Abciximab ; Clinical Trials as Topic ; Coronary Disease/mortality ; Coronary Disease/therapy ; Eptifibatide ; Humans ; Treatment Outcome
Czasopismo naukowe
Tytuł:
Educational program to reduce major bleeding in patients undergoing percutaneous coronary interventions and receiving abciximab.
Autorzy:
Dobesh PP; Division of Pharmacy, St. Louis College of Pharmacy (SLCP), 4588 Parkview Place, St. Louis, MO 63110, USA. />Lakamp JE
Pokaż więcej
Źródło:
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists [Am J Health Syst Pharm] 2002 Aug 15; Vol. 59 (16), pp. 1539-42.
Typ publikacji:
Journal Article
MeSH Terms:
Angioplasty, Balloon, Coronary*
Patient Education as Topic*
Antibodies, Monoclonal/*adverse effects
Anticoagulants/*adverse effects
Hemorrhage/*chemically induced
Hemorrhage/*prevention & control
Immunoglobulin Fab Fragments/*adverse effects
Platelet Aggregation Inhibitors/*adverse effects
Abciximab ; Aged ; Female ; Hemorrhage/economics ; Heparin/adverse effects ; Humans ; Male ; Middle Aged ; Retrospective Studies
Czasopismo naukowe
Tytuł:
Elective or selective use of abciximab?
Autorzy:
Butler R
Samani NJ
Pokaż więcej
Źródło:
Lancet (London, England) [Lancet] 2000 Feb 26; Vol. 355 (9205), pp. 755.
Typ publikacji:
Letter; Comment
MeSH Terms:
Angioplasty, Balloon, Coronary*
Antibodies, Monoclonal/*economics
Immunoglobulin Fab Fragments/*economics
Platelet Aggregation Inhibitors/*economics
Abciximab ; Cost-Benefit Analysis ; Female ; Humans ; Male ; Middle Aged ; Stents
Opinia redakcyjna
Tytuł:
Randomised placebo-controlled trial of abciximab before and during coronary intervention in refractory unstable angina: the CAPTURE Study.
Źródło:
Lancet (London, England) [Lancet] 1997 May 17; Vol. 349 (9063), pp. 1429-35.
Typ publikacji:
Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial
MeSH Terms:
Angioplasty, Balloon, Coronary*/adverse effects
Angina, Unstable/*therapy
Antibodies, Monoclonal/*pharmacology
Immunoglobulin Fab Fragments/*pharmacology
Platelet Aggregation Inhibitors/*pharmacology
Abciximab ; Female ; Follow-Up Studies ; Humans ; Male ; Middle Aged ; Myocardial Infarction/etiology ; Myocardial Infarction/prevention & control ; Recurrence ; Treatment Outcome
Czasopismo naukowe
    Wyświetlanie 1-19 z 19

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies